K. Riesbeck
Dept. of Immunology
MRC Clinical Sciences Centre
London
UK
Name/email consistency: high
- Human tissue factor pathway inhibitor fused to CD4 binds both FXa and TF/FVIIa at the cell surface. Riesbeck, K., Dorling, A., Kemball-Cook, G., McVey, J.H., Jones, M., Tuddenham, E.G., Lechler, R.I. Thromb. Haemost. (1997)